B-cell Malignancies: Clinical Trials

2 trials for B-cell Malignancies, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 terminated. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Recruiting 1, Terminated 1

Follow B-cell Malignancies: new trials by email Literature Review of B-cell Malignancies trials Research Report on B-cell Malignancies

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
JY231(JY231) Injection for the Treatment of R/R B-cell Malignancies
JY231 Injection - B-cell Malignancies
Not applicableRecruiting920th Hospital of Joint Logistics Support Force of People's Liberation Army of China362025-07-012025-07-15
A Phase I/II Multiple Center Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Malignancies
Therapeutic 4SCAR19 cells - B-cell Malignancies
Not applicableTerminatedShenzhen Geno-Immune Medical Institute2002025-05-012026-10-30

Narrower conditions

Leukemia, B-Cell (1)

Broader conditions

Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Lymphatic Diseases (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Sponsors

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China (1)  ·  Shenzhen Geno-Immune Medical Institute (1)

Countries

China (2)

Top investigators

Lung-Ji Chang (1)

Results publications

PMID 30444200